Myocardial bridges spared from atherosclerosis: overview of the underlying mechanisms

Yiannis S Chatzizisis1, George D Giannoglou

  • 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. joc@med.auth.gr

Insights

Myocardial bridges, a congenital coronary anomaly, seem protected from atherosclerosis. This protection may stem from the unique hemodynamic environment within the bridge, offering insights into preventing heart disease.

Area of Science:

  • Cardiovascular Research
  • Pathophysiology
  • Medical Science

Background:

  • Myocardial bridging is a congenital coronary artery anomaly where a segment tunnels through the heart muscle.
  • Clinically and histopathologically, myocardial bridges show resistance to atherosclerosis.
  • The protective mechanisms against atherosclerosis within myocardial bridges are not fully understood.

Purpose of the Study:

  • To investigate the mechanisms behind the apparent atheroprotection observed in myocardial bridges.
  • To explore the role of the surrounding myocardium in creating a unique microenvironment within myocardial bridges.
  • To lay the groundwork for developing novel atheroprotective strategies based on these findings.

Main Methods:

  • Analysis of clinical and histopathological data related to myocardial bridges.
  • Hypothesizing the role of hemodynamic factors (low tensile stress, high shear stress) within the bridge.
  • Considering the influence of myocardial support on coronary wall motion.

Main Results:

  • Myocardial bridges appear to be a site spared from atherosclerotic development.
  • The surrounding myocardium is implicated in generating an atheroprotective hemodynamic microenvironment.
  • Key factors include low tensile stress and high shear stress within the bridge.

Conclusions:

  • The unique microenvironment within myocardial bridges, influenced by surrounding myocardium, contributes to atheroprotection.
  • Understanding these mechanisms is crucial for advancing the study of atherosclerosis pathophysiology.
  • Further investigation in animal models could lead to new atheroprotective therapies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...